Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

Support Care Cancer. 2017 Feb;25(2):351-352. doi: 10.1007/s00520-016-3238-7. Epub 2016 Apr 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw
  • Bone Density Conservation Agents
  • Denosumab*
  • Diphosphonates
  • Humans
  • Jaw Diseases
  • Osteonecrosis*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Denosumab